Chemours (CC)
(Delayed Data from NYSE)
$20.38 USD
+0.60 (3.03%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $20.39 +0.01 (0.05%) 6:14 PM ET
5-Strong Sell of 5 5
D Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/24/24 |
---|---|
Current Quarter | 0.32 |
EPS Last Quarter | 0.38 |
Last EPS Surprise | -42.42% |
ABR | 2.44 |
Earnings ESP
|
-12.50% |
---|---|
Current Year | 1.32 |
Next Year | 2.20 |
EPS (TTM) | 1.65 |
P/E (F1) | 15.01 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.43B | 1.35B | 5.70B | 6.03B |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 1.45B | 1.37B | 5.82B | 6.13B |
Low Estimate | 1.39B | 1.32B | 5.59B | 5.99B |
Year ago Sales | 1.49B | 1.36B | 6.03B | 5.70B |
Year over Year Growth Est. | -4.16% | -1.15% | -5.46% | 5.90% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.32 | 0.30 | 1.32 | 2.20 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | 0.38 | 0.18 | 1.26 | 2.40 |
High Estimate | 0.38 | 0.57 | 1.55 | 2.40 |
Low Estimate | 0.28 | 0.15 | 1.11 | 2.04 |
Year ago EPS | 0.64 | 0.31 | 2.82 | 1.32 |
Year over Year Growth Est. | -50.00% | -3.23% | -53.19% | 66.67% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 0 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 3 | 2 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.32 | 0.30 | 1.32 | 2.20 |
7 Days Ago | 0.33 | 0.31 | 1.33 | 2.22 |
30 Days Ago | 0.33 | 0.31 | 1.33 | 2.22 |
60 Days Ago | 0.46 | 0.20 | 1.60 | 2.65 |
90 Days Ago | 0.59 | 0.29 | 1.88 | 3.26 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.28 | 0.15 | 1.11 | 2.04 |
Zacks Consensus Estimate | 0.32 | 0.30 | 1.32 | 2.20 |
Earnings ESP | -12.50% | -50.41% | -15.75% | -7.17% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.38 | 0.32 | 0.31 | 0.64 | NA |
Estimate | 0.66 | 0.25 | 0.29 | 0.77 | NA |
Difference | -0.28 | 0.07 | 0.02 | -0.13 | -0.08 |
Surprise | -42.42% | 28.00% | 6.90% | -16.88% | -6.10% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more